Skip to main content

and
  1. No Access

    Article

    Granisetron versus tropisetron for prophylaxis of acute chemotherapy-induced emesis: a pooled analysis

    This analysis compares the antiemetic efficacy of the 5-HT3-receptor antagonists granisetron and tropisetron in acute chemotherapy-induced nausea and vomiting (CINV). All published randomized studies comparing gr...

    Karin Jordan, Axel Hinke, Axel Grothey, Hans Joachim Schmoll in Supportive Care in Cancer (2005)

  2. Article

    MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy

    Previous pilot data suggested that venlafaxine could prevent acute and chronic oxaliplatin-related neuropathy. The purpose of this randomized, placebo-controlled, double-blinded pilot study was to obtain addit...

    Collin Zimmerman, Pamela J. Atherton, Deirdre Pachman in Supportive Care in Cancer (2016)

  3. No Access

    Article

    Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505)

    Oxaliplatin and paclitaxel are commonly used chemotherapies associated with acute and chronic neuropathies. There is a need to better understand the similarities and differences of these clinical syndromes.

    Deirdre R. Pachman, Rui Qin, Drew Seisler in Supportive Care in Cancer (2016)

  4. No Access

    Article

    Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicine

    The most common adverse event (AE) of dabrafenib and trametinib (DT) is pyrexia, which has been reported to occur in up to 71% of patients. Pyrexia resulted in therapy discontinuation in up to 26% of patients ...

    Jesus Vera, Jonas Paludo, Lisa Kottschade, Jessica Brandt in Supportive Care in Cancer (2019)